Overview

Synthetic Biology Market is poised to register a CAGR of 26.5% during the forecast period 2022 to 2028..

An area of synthetic biology involves the fusion of multiple disciplines, including molecular biology, biotechnology, biophysics, genetic engineering, and others. A top-down approach is used primarily in synthetic biology, whereas a bottom-up approach is mainly used. For the top-down approach, existing biological systems are redesigned and fabricated for the purpose of producing synthetic products. As part of the bottom-up approach, bioengineers create bioengineered devices and systems from scratch that are not present in nature. It is evident that the synthetic biology industry arose out of a pressing need to understand the functions of genetic elements, cells, and biological processes. Pharmaceutical & diagnostics, energy, bioplastics, and environmental products developed in this new biological system are used across a wide range of industries. There are a number of factors driving the growth of the synthetic biology market, including government support, the proliferation of companies developing synthetic biology, and the decline of DNA sequencing and synthesizing costs. Rather than stimulating industry growth, bio-safety & bio-security concerns would impede it. In the future, synthetic biology will continue to pose a key challenge due to the misuse of technology or the possibility of pathogens being accidentally released into the atmosphere. In the market, however, there are lucrative opportunities due to rising demand for biofuels, growing awareness among emerging economies, and increasing R&D investments for synthetic drugs and vaccines.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Synthetic Biology Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Synthetic Biology Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Synthetic Biology Market:
• Thermo Fisher Scientific
• Merck KGaA
• Agilent Technologies, Inc.
• Novozymes A/S
• Ginkgo Bioworks
• Amyris
• Precigen
• GenScript Biotech Corporation
• Twist Bioscience
• Synthetic Genomics
• Codexis
• Synthego
• Creative Enzymes
• Eurofins Scientific
• Cyrus Biotechnology
• ATUM
• TeselaGen
• Arzeda
• Integrated DNA Technologies
• New England Biolabs
• Royal DSM
• OriGene Technologies
• Genomatica
• Illumina
• Scarab Genomics
(Note: The list of the major players will be updated with the latest market scenario and trends)

Synthetic Biology Market Segmentation:
By Tool
• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-nucleic Acids

By Technology
• Gene Synthesis
• Genome Engineering
• Sequencing
• Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modeling
• Microfluidics
• Nanotechnology

By Application
• Medical Application
  o Pharmaceuticals
  o Drug Discovery and Therapeutics
    • Cancer Detection & Diagnostics
    • Other Drug Discovery and Therapeutic Applications
• Artificial Tissue and Tissue Regeneration
  o Bio-synthesis
  o Stem Cell Regulation
  o Other Tissue and Tissue Regeneration Applications
• Industrial Applications
  o Biofuel and Renewable Energy
  o Biomaterials and Green Chemicals
  o Industrial Enzymes, by Application
    • Textile Industry
    • Paper Industry
    • Consumer Care Industry
      o Skin Care & Cosmetics
      o Other Consumer Care Products
    • Other Industries
• Food & Agriculture
• Environmental Applications
  o Bioremediation
  o Biosensing

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Synthetic Biology Market By Tool, By Technology, By Application and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Synthetic Biology Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Synthetic Biology Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Synthetic Biology Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Synthetic Biology Market, By Tool Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Oligonucleotides and Synthetic DNA
   7.2. Enzymes
   7.3. Cloning Technologies Kits
   7.4. Synthetic Cells
   7.5. Chassis Organisms
   7.6. Xeno-nucleic Acids

8. Synthetic Biology Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Gene Synthesis
   8.2. Genome Engineering
   8.3. Sequencing
   8.4. Bioinformatics
   8.5. Site-directed Mutagenesis
   8.6. Cloning
   8.7. Measurement and Modeling
   8.8. Microfluidics
   8.9. Nanotechnology

9. Synthetic Biology Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Medical Application
        9.1.1. Pharmaceuticals
        9.1.2. Drug Discovery and Therapeutics
               9.1.1.1. Cancer Detection & Diagnostics
               9.1.1.2. Other Drug Discovery and Therapeutic Applications
   9.2. Artificial Tissue and Tissue Regeneration
        9.2.1. Bio-synthesis
        9.2.2. Stem Cell Regulation
        9.2.3. Other Tissue and Tissue Regeneration Applications
   9.3. Industrial Applications
        9.3.1. Biofuel and Renewable Energy
        9.3.2. Biomaterials and Green Chemicals
        9.3.3. Industrial Enzymes, by Application
               9.3.3.1. Textile Industry
               9.3.3.2. Paper Industry
               9.3.3.3. Consumer Care Industry
                        9.3.3.3.1. Skin Care & Cosmetics
                        9.3.3.3.2. Other Consumer Care Products
               9.3.3.4. Other Industries
   9.4. Food & Agriculture
   9.5. Environmental Applications
        9.5.1. Bioremediation
        9.5.2. Biosensing

10. North America Synthetic Biology Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Synthetic Biology Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Synthetic Biology Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Synthetic Biology Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1. Thermo Fisher Scientific
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. Merck KGaA
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. Agilent Technologies, Inc.
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. Novozymes A/S
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5. Ginkgo Bioworks
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6. Amyris
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview      
    16.7. Precigen
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
    16.8. GenScript Biotech Corporation
          16.8.1. Company Overview
          16.8.2. Product Portfolio
          16.8.3. SWOT Analysis
          16.8.4. Financial Overview
          16.8.5. Strategic Overview 
    16.9. Twist Bioscience
          16.9.1. Company Overview
          16.9.2. Product Portfolio
          16.9.3. SWOT Analysis
          16.9.4. Financial Overview
          16.9.5. Strategic Overview 
    16.10.Synthetic Genomics
          16.10.1. Company Overview
          16.10.2. Product Portfolio
          16.10.3. SWOT Analysis
          16.10.4. Financial Overview
          16.10.5. Strategic Overview 
    16.11.Codexis
          16.11.1. Company Overview
          16.11.2. Product Portfolio
          16.11.3. SWOT Analysis
          16.11.4. Financial Overview
          16.11.5. Strategic Overview      
    16.12.Synthego
          16.12.1. Company Overview
          16.12.2. Product Portfolio
          16.12.3. SWOT Analysis
          16.12.4. Financial Overview
          16.12.5. Strategic Overview
    16.13.Creative Enzymes
          16.13.1. Company Overview
          16.13.2. Product Portfolio
          16.13.3. SWOT Analysis
          16.13.4. Financial Overview
          16.13.5. Strategic Overview
    16.14.Eurofins Scientific
          16.14.1. Company Overview
          16.14.2. Product Portfolio
          16.14.3. SWOT Analysis
          16.14.4. Financial Overview
          16.14.5. Strategic Overview 
    16.15.Cyrus Biotechnology
          16.15.1. Company Overview
          16.15.2. Product Portfolio
          16.15.3. SWOT Analysis
          16.15.4. Financial Overview
          16.15.5. Strategic Overview 
    16.16.ATUM
          16.16.1. Company Overview
          16.16.2. Product Portfolio
          16.16.3. SWOT Analysis
          16.16.4. Financial Overview
          16.16.5. Strategic Overview      
    16.17.TeselaGen
          16.17.1. Company Overview
          16.17.2. Product Portfolio
          16.17.3. SWOT Analysis
          16.17.4. Financial Overview
          16.17.5. Strategic Overview
    16.18.Arzeda
          16.18.1. Company Overview
          16.18.2. Product Portfolio
          16.18.3. SWOT Analysis
          16.18.4. Financial Overview
          16.18.5. Strategic Overview
    16.19.Integrated DNA Technologies
          16.19.1. Company Overview
          16.19.2. Product Portfolio
          16.19.3. SWOT Analysis
          16.19.4. Financial Overview
          16.19.5. Strategic Overview
    16.20.New England Biolabs
          16.20.1. Company Overview
          16.20.2. Product Portfolio
          16.20.3. SWOT Analysis
          16.20.4. Financial Overview
          16.20.5. Strategic Overview
    16.21.Royal DSM
          16.21.1. Company Overview
          16.21.2. Product Portfolio
          16.21.3. SWOT Analysis
          16.21.4. Financial Overview
          16.21.5. Strategic Overview 
    16.22.OriGene Technologies
          16.22.1. Company Overview
          16.22.2. Product Portfolio
          16.22.3. SWOT Analysis
          16.22.4. Financial Overview
          16.22.5. Strategic Overview 
    16.23.Genomatica
          16.23.1. Company Overview
          16.23.2. Product Portfolio
          16.23.3. SWOT Analysis
          16.23.4. Financial Overview
          16.23.5. Strategic Overview      
    16.24.Illumina
          16.24.1. Company Overview
          16.24.2. Product Portfolio
          16.24.3. SWOT Analysis
          16.24.4. Financial Overview
          16.24.5. Strategic Overview
    16.25.Scarab Genomics
          16.25.1. Company Overview
          16.25.2. Product Portfolio
          16.25.3. SWOT Analysis
          16.25.4. Financial Overview
          16.25.5. Strategic Overview 

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the healthcare regulations initiated by administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures